TWST News and Press, Twist Bioscience Corporation From 11/17/23

2023-11-17 07:36:00 ET More on Twist Bioscience A New Look At Twist Bioscience Twist Bioscience: Progress Hidden By Execution Issues And Soft Demand Twist Bioscience inks antibody research deal with Bayer Twist Bioscience in pact with Japan-based Ono for auto...

-- Record revenue of $245.1 million in Fiscal 2023; Increase of 20% over $203.6 million in Fiscal 2022 -- -- Orders increased to $264 million in Fiscal 2023; Increase of 17% over $226.4 million in Fiscal 2022 -- — Expect revenue in the range of $285 million to $290 million for full...

Bank of China Ltd. ADR (BACHY) is expected to report for Q2 2024 China Health Industries Holdings Inc (CHHE) is expected to report for quarter end 2023-09-30 Nitori Holdings Co., Ltd. ADR (NCLTY) is expected to report for Q2 2024 China Minsheng Banking Corporation Ltd. ADR (CMAKY) is ...

Twist Bioscience Corporation (TWST) is expected to report $-0.94 for Q4 2023

2023-11-16 11:53:39 ET More on Twist Bioscience A New Look At Twist Bioscience Twist Bioscience: Progress Hidden By Execution Issues And Soft Demand Twist Bioscience inks antibody research deal with Bayer Twist Bioscience in pact with Japan-based Ono for auto...

Clonally perfect genes shipped in as few as five business days Launch of ‘fast genes’ enabled by state-of-the-art Wilsonville manufacturing facility Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-qual...

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience, and Jim Thorburn, CFO of Twist Bioscience, wil...

2023-11-12 08:19:00 ET Also reporting: SNDL FSR ZOM TSN CARA DAC SBLK OTCQB:CBWTF TSEM Also reporting: AAP CTLT CPA DAVA GLBE GFF HI JJSF JD MAXN PANW SQM SONO TJX XPEV Also reporting: ...

As required by the rules of the Nasdaq Stock Market, Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it has granted a total of 130,400 restricted stock units (&...

2023-11-02 16:55:06 ET Summary Today, we take a look synthetic biology company Twist Bioscience Corporation for the first time since spring. The company recently signed collaboration deals with two new drugmakers and saw upward analyst price target revisions after strong Q2 result...